Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Quercetin may help improve symptoms of polycystic ovary syndrome.

A woman had a rare liver tumor causing male-like physical changes, highlighting the need for thorough checks when such symptoms appear.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The document concludes that managing PCOS involves lifestyle changes, medication for symptoms, and weight loss for fertility improvement.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

The healthcare for transgender veterans could be better with a more unified team approach.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

The lemur's testicular tumor was removed, improving its coat and behavior, with no signs of cancer spread.

High prolactin levels can cause skin and hair symptoms similar to those caused by hormone imbalances.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Perforin and granzyme-B may influence hormone levels in women with PCOS.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.